A recent news update in the Daily Mail reported a new OBEClust position paper published in the Lancet Regional Health – Europe. Despite ongoing innovation in obesity care, obesity remains a major public health problem. While new treatments, such as GLP-1 receptor agonists, represent a significant breakthrough in pharmacological management, they fail to address the underlying causes of obesity. Experts emphasise that prevention remains essential, highlighting the need for more personalised and effective prevention strategies.

Mentioned also on: Al-Wafd Online Portal (in Arabic)